Stockreport

Scholar Rock: Apitegromab's Path Forward Remains Intact, Maintaining Buy Rating [Seeking Alpha]

Scholar Rock Holding Corporation  (SRRK) 
Last scholar rock holding corporation earnings: 11/12 07:30 am Check Earnings Report
PDF FDA setbacks are manufacturing-related, not clinical, with no new efficacy or safety concerns; remediation and a second CDMO are underway. Topline phase 3 data suppor [Read more]